Brind.
  1. Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
  2. The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.

An HHS official commented on an FDA program, following Marty Makary's departure from the agency.

1 report, 1 independent Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

An HHS official commented on an FDA program, following Marty Makary's departure from the agency.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped